Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This clinical trial study is two-stage, multi-center, randomized, double-blind, placebo controlled, phase 3 clinical trial to evaluate the efficacy and safety of FURESTEM-AD Inj. for moderate to severe chronic atopic dermatitis.
Epistemonikos ID: ed1279ddf45e61d1aba04702a08a359dc32f17a6
First added on: Dec 20, 2022